LOS ANGELES, Oct. 26 /PRNewswire-HISPANIC PR WIRE/ — Today, Grifols S.A. (Grifols), a global healthcare company based in Barcelona, Spain, hosted the Spanish Minister of Industry, Tourism and Trade, Miguel Sebastian, at its US corporate offices and production facilities in Los Angeles, California. The Minister’s visit to Grifols facilities is part of a larger tour by the Minister of prominent Spain-based businesses throughout the US that is designed to increase institutional and business cooperation between Spain and the United States in priority business sectors and to promote the presence of Spanish companies in US markets.
“It is an honor to host Minister Sebastian at our facilities,” said Gregory Rich, President of Grifols’ US operations. “Our extensive capital investments in the US over the past few years reflect how important the US is to the global success of the company.” A number of senior Grifols executives from the US and Spain were on-hand to welcome Minister Sebastian including Victor Grifols, the President and CEO of Grifols, S.A.
Although Grifols has been present in the US since 1990, the company significantly increased its US presence in 2002 with the acquisition of a company dedicated to the collection and testing of human plasma for production of life-saving plasma therapies. In 2003 Grifols acquired its Los Angeles based production facilities and corporate offices. Between 2003 to 2007 Grifols invested more than 300 million euro in US facilities and has an additional 210 million euro in capital investments planned for the period 2008 to 2012. Earlier this month Grifols began construction on phase one of a three phase 50 million euro expansion plan in San Marcos, Texas that includes a national testing laboratory, warehousing and production facilities.
The Ministry of Industry, Tourism and Trade is the department within the Spanish general administration responsible for proposing and carrying out government policy in the areas of industrial development and innovation, trade policy, small and medium sized enterprises, energy and mining, tourism, telecommunications, audiovisual media and the development of the Information Society. Additionally, the Ministry of Industry, Tourism and Trade is responsible for submitting to the government the proposal for Spain’s positioning on issues that fall within the scope of the department.
Grifols S.A. is a Spain-based company in the healthcare sector involved in the research, development, manufacturing and marketing of plasma therapies, IV therapy solutions, enteral and parenteral nutrition, diagnostic systems, pharmacy automation, and medical materials and devices. Grifols plasma therapies are produced from plasma obtained at 80 donor centers across the US and are used to treat a variety of rare and life-threatening diseases. Founded in 1940, Grifols currently operates in 90 countries with more than 6,000 employees and 26 subsidiaries. Grifols is listed on the Ibex-35 stock market with combined gross revenues over 814 million euro.
For more information about Grifols please visit www.grifols.com
SOURCE Grifols S.A.